Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
4.080
0.00 (0.00%)
At close: Mar 27, 2026
Jiangsu Recbio Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 351.84 | 319.04 | 834.98 | 1,325 | 1,183 |
Short-Term Investments | - | 131.31 | 2.78 | 3.85 | 2.96 |
Cash & Short-Term Investments | 351.84 | 450.35 | 837.76 | 1,329 | 1,186 |
Cash Growth | -21.87% | -46.24% | -36.96% | 12.10% | 73.07% |
Accounts Receivable | 0.67 | - | - | - | - |
Other Receivables | - | 93.89 | 38.57 | 12.58 | 51.94 |
Receivables | 0.67 | 93.89 | 38.57 | 12.58 | 51.94 |
Inventory | 40.99 | 63.48 | 118.08 | 66.14 | 38.55 |
Other Current Assets | 144.67 | 47.41 | 134.97 | 12.2 | 18.57 |
Total Current Assets | 538.16 | 655.13 | 1,129 | 1,420 | 1,295 |
Property, Plant & Equipment | 1,052 | 1,089 | 884.23 | 631.25 | 471.61 |
Long-Term Investments | - | 3.9 | 2.4 | 31.4 | 80 |
Goodwill | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 |
Other Intangible Assets | 32.55 | 37.43 | 41.13 | 33.51 | 22.12 |
Long-Term Deferred Charges | - | 71.3 | - | - | - |
Other Long-Term Assets | 129.41 | 73.75 | 119.84 | 184.22 | 41.62 |
Total Assets | 1,762 | 1,940 | 2,186 | 2,310 | 1,919 |
Accounts Payable | 16.97 | 59.79 | 115.08 | 62.52 | 16.82 |
Accrued Expenses | - | 159.82 | 118.82 | 148.8 | 53.46 |
Current Portion of Long-Term Debt | 249.93 | 499.38 | 46.31 | 1.39 | - |
Current Portion of Leases | 12.72 | 10.84 | 14.73 | 20.36 | 7.86 |
Current Unearned Revenue | 10.8 | - | - | - | - |
Other Current Liabilities | 247.83 | 109.6 | 149.29 | 95.91 | 61.15 |
Total Current Liabilities | 538.25 | 839.42 | 444.24 | 328.98 | 139.29 |
Long-Term Debt | 369.76 | 378.88 | 585.33 | 231.62 | 50 |
Long-Term Leases | 6.07 | - | 4.42 | 29.25 | 18.86 |
Long-Term Unearned Revenue | 47.61 | 58.9 | 75.81 | 61.14 | 32.24 |
Long-Term Deferred Tax Liabilities | 5.53 | 5.53 | 5.53 | 5.53 | 5.53 |
Other Long-Term Liabilities | 88.79 | 128.18 | - | - | - |
Total Liabilities | 1,056 | 1,411 | 1,115 | 656.53 | 245.92 |
Common Stock | 626.08 | 482.96 | 482.96 | 482.96 | 448.25 |
Additional Paid-In Capital | - | 2,583 | 2,583 | 2,583 | 1,954 |
Retained Earnings | - | -2,897 | -2,334 | -1,754 | -1,031 |
Treasury Stock | -101.28 | -68.28 | -54.01 | - | - |
Comprehensive Income & Other | 181.05 | 428.31 | 393.76 | 349.44 | 301.63 |
Total Common Equity | 705.84 | 529.32 | 1,071 | 1,662 | 1,673 |
Minority Interest | - | - | -0.49 | -8.8 | -0.01 |
Shareholders' Equity | 705.84 | 529.32 | 1,071 | 1,653 | 1,673 |
Total Liabilities & Equity | 1,762 | 1,940 | 2,186 | 2,310 | 1,919 |
Total Debt | 638.47 | 889.1 | 650.8 | 282.63 | 76.72 |
Net Cash (Debt) | -286.63 | -438.75 | 186.97 | 1,046 | 1,109 |
Net Cash Growth | - | - | -82.13% | -5.63% | 68.29% |
Net Cash Per Share | -0.54 | -0.92 | 0.39 | 2.21 | 2.63 |
Filing Date Shares Outstanding | 584.19 | 477.37 | 479.15 | 482.96 | 448.25 |
Total Common Shares Outstanding | 584.19 | 477.37 | 479.15 | 482.96 | 448.25 |
Working Capital | -0.09 | -184.29 | 685.14 | 1,091 | 1,155 |
Book Value Per Share | 1.21 | 1.11 | 2.24 | 3.44 | 3.73 |
Tangible Book Value | 663.99 | 482.59 | 1,021 | 1,619 | 1,642 |
Tangible Book Value Per Share | 1.14 | 1.01 | 2.13 | 3.35 | 3.66 |
Machinery | - | 569.97 | 291.14 | 198 | 144.58 |
Construction In Progress | - | 493.73 | 493.71 | 381.73 | 266.74 |
Leasehold Improvements | - | 150.91 | 150.38 | 30.06 | 29.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.